Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 02, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 8th Annual JMP Securities Healthcare Conference

LAKE OSWEGO, Ore., July 2, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
June 03, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Provides Product Pipeline Update at the ASCO 2013 Annual Meeting

In completed Phase 1/2 trials of NeuVax™ (nelipepimut-S), patients who exhibit robust in vitro immunologic response have lower recurrence rates. NeuVax companion diagnostic, the Leica...
May 30, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Jefferies 2013 Global Healthcare Conference

LAKE OSWEGO, Ore., May 30, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
May 23, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 2013 Marcum MicroCap Conference

LAKE OSWEGO, Ore., May 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
May 09, 2013 16:05 ET | Source: Galena Biopharma, Inc.

VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results

Lead product, NeuVax™ (nelipepimut-S), reached global site enrollment milestone for Phase 3 PRESENT trial; and commenced enrolling a Phase 2b in combination with...
May 09, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting

Abstral® (fentanyl) Sublingual Tablets are an important new treatment option for inadequately controlled breakthrough cancer pain (BTcP) which impacts the majority of cancer patients at some...
May 01, 2013 07:05 ET | Source: Galena Biopharma, Inc.

William L. Ashton Joins Galena Biopharma's Board of Directors

LAKE OSWEGO, Ore., May 1, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
April 24, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference

LAKE OSWEGO, Ore., April 24, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
April 16, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 2013 BIO International Convention

LAKE OSWEGO, Ore., April 16, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...
March 29, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference

LAKE OSWEGO, Ore., March 29, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical...